{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Chinese herbal medicine", "chemotherapy-induced peripheral neuropathy", "colorectal cancer", "hand and foot syndrome", "herbal medicine", "integrative medicine", "meta-analysis", "systematic review"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30526124", "DateCompleted": {"Year": "2019", "Month": "12", "Day": "12"}, "DateRevised": {"Year": "2020", "Month": "06", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "12", "Day": "10"}], "Language": ["eng"], "ELocationID": ["1534735418817833", "10.1177/1534735418817833"], "Journal": {"ISSN": "1552-695X", "JournalIssue": {"Volume": "18", "PubDate": {"Year": "2019", "Season": "Jan-Dec"}}, "Title": "Integrative cancer therapies", "ISOAbbreviation": "Integr Cancer Ther"}, "ArticleTitle": "Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis.", "Pagination": {"StartPage": "1534735418817833", "MedlinePgn": "1534735418817833"}, "Abstract": {"AbstractText": ["To assess the clinical evidence for integrative herbal medicine therapy in the management of chemotherapy-induced peripheral neuropathy (CIPN) and hand-foot syndrome (HFS) resulting from treatments for colorectal cancer (CRC).", "Randomized controlled trials (RCTs) were identified from major English and Chinese databases. Participants had been diagnosed with CRC by pathology and had received or were undergoing chemotherapy. Interventions included herbal medicines administered orally or topically. Controls were placebo, supportive care or conventional chemotherapy for CRC. Methods followed the Cochrane handbook. Meta-analyses were grouped by study design, outcome measure, severity, and chemotherapy. Random-effects models with 95% confidence intervals were used. Heterogeneity was assessed as I<sup>2</sup>.", "Sixty-three RCTs (4286 participants) were included. Five used a placebo in the control groups. Fifty-eight studies tested oral herbal medicine, and 5 tested topical herbal medicine. Data were available for CIPN (60 studies) and HFS (12 studies). Fifty-seven studies combined orally administered herbal medicine with chemotherapy compared with the same chemotherapy. For CIPN, 33 studies used World Health Organization (WHO) criteria, 7 used Levi's criteria, and 10 used the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE). These were analyzed separately. For grades III + IV CIPN, there was a significant reduction in the integrative groups for WHO (relative risk [RR] 0.42 [0.23, 0.77], I<sup>2</sup> = 0%) and Levi's (RR 0.28 [0.11, 0.69], I<sup>2</sup> = 0%) but not NCI-CTCAE (RR 0.65 [0.37, 1.13], I<sup>2</sup> = 26.4%). Hand and foot baths showed no differences for Levi's grades III + IV CIPN but a significant reduction in all grades (RR 0.69 [0.50, 0.95], I<sup>2</sup> = 68.8%). For HFS (all grades) there was a significant reduction in the integrative groups for WHO (RR 0.62 [0.41, 0.96], I<sup>2</sup> = 22%) but not for NCI-CTCAE (RR 0.93 [0.55, 1.55], I<sup>2</sup> = 75.7%). Sensitivity analyses explored sources of heterogeneity.", "Integrative herbal therapy appeared to reduce CIPN and HFS in people receiving chemotherapy for CRC. However, the strength of the evidence was limited by lack of blinding in most studies, potential for bias, and relatively short study durations."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, and The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China."}], "LastName": "Liu", "ForeName": "Yihong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "2 China-Australia International Research Centre for Chinese Medicine, School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia."}], "LastName": "May", "ForeName": "Brian H", "Initials": "BH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "2 China-Australia International Research Centre for Chinese Medicine, School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia."}], "LastName": "Zhang", "ForeName": "Anthony Lin", "Initials": "AL"}, {"Identifier": ["0000-0003-2699-9740"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, and The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China."}], "LastName": "Guo", "ForeName": "Xinfeng", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, and The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China."}], "LastName": "Lu", "ForeName": "Chuanjian", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, and The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China."}, {"Identifier": [], "Affiliation": "2 China-Australia International Research Centre for Chinese Medicine, School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia."}], "LastName": "Xue", "ForeName": "Charlie Changli", "Initials": "CC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, and The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China."}], "LastName": "Zhang", "ForeName": "Haibo", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Meta-Analysis", "Research Support, Non-U.S. Gov't", "Systematic Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Integr Cancer Ther", "NlmUniqueID": "101128834", "ISSNLinking": "1534-7354"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}], "MeshHeadingList": [{"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Colorectal Neoplasms"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Hand-Foot Syndrome"}, {"QualifierName": ["methods"], "DescriptorName": "Herbal Medicine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["methods"], "DescriptorName": "Integrative Medicine"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Peripheral Nervous System Diseases"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "<b>Declaration of Conflicting Interests:</b> The author(s) declared no potential conflicts of interest with respect to the\nresearch, authorship, and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359-E386.", "ArticleIdList": ["25220842"]}, {"Citation": "Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115-132.", "ArticleIdList": ["26808342"]}, {"Citation": "Zhu J, Tan Z, Hollis-Hansen K, et al. Epidemiological trends in colorectal cancer in China: an ecological study. Dig Dis Sci. 2017;62:235-243.", "ArticleIdList": ["27796769"]}, {"Citation": "Flatters SJL, Dougherty PM, Colvin LA. Clinical and preclinical perspectives on chemotherapy-induced peripheral neuropathy (CIPN): a narrative review. Br J Anaesth. 2017;119:737-749.", "ArticleIdList": ["29121279"]}, {"Citation": "Seretny M, Currie GL, Sena ES, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155:2461-2470.", "ArticleIdList": ["25261162"]}, {"Citation": "Cioroiu C, Weimer LH. Update on chemotherapy-induced peripheral neuropathy. Curr Neurol Neurosci Rep. 2017;17:47.", "ArticleIdList": ["28421360"]}, {"Citation": "de Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol. 1997;15:808-815.", "ArticleIdList": ["9053508"]}, {"Citation": "Cassidy J, Clarke S, Diaz-Rubio E, et al. Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. J Clin Oncol. 2008;26:2006-2012.", "ArticleIdList": ["18421053"]}, {"Citation": "Nikolaou V, Syrigos K, Saif MW. Incidence and implications of chemotherapy related hand-foot syndrome. Expert Opin Drug Saf. 2016;15:1625-1633.", "ArticleIdList": ["27718746"]}, {"Citation": "Kwakman JJ, Punt CJ. Oral drugs in the treatment of metastatic colorectal cancer. Expert Opin Pharmacother. 2016;17:1351-1361.", "ArticleIdList": ["27156856"]}, {"Citation": "Avan A, Postma TJ, Ceresa C, et al. Platinum-induced neurotoxicity and preventive strategies: past, present, and future. Oncologist. 2015;20:411-432.", "ArticleIdList": ["PMC4391771", "25765877"]}, {"Citation": "Poupon L, Kerckhove N, Vein J, et al. Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives. Expert Opin Drug Saf. 2015;14:1269-1282.", "ArticleIdList": ["26058312"]}, {"Citation": "Brewer JR, Morrison G, Dolan ME, Fleming GF. Chemotherapy-induced peripheral neuropathy: current status and progress. Gynecol Oncol. 2016;140:176-183.", "ArticleIdList": ["PMC4698212", "26556766"]}, {"Citation": "Chen XF, Wang R, Yin YM, et al. The effect of monosialotetrahexosylganglioside (GM1) in prevention of oxaliplatin induced neurotoxicity: a retrospective study. Biomed Pharmacother. 2012;66:279-284.", "ArticleIdList": ["22397758"]}, {"Citation": "Zhu Y, Yang J, Jiao S, Ji T. Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors. World J Surg Oncol. 2013;11:19.", "ArticleIdList": ["PMC3575266", "23351188"]}, {"Citation": "Scontre VA, Martins JC, de Melo Sette CV, et al. Curcuma longa (turmeric) for prevention of capecitabine-induced hand-foot syndrome: a pilot study. J Diet Suppl. 2018;15:606-612.", "ArticleIdList": ["29095653"]}, {"Citation": "Elyasi S, Shojaee FSR, Allahyari A, Karimi G. Topical silymarin administration for prevention of capecitabine-induced hand-foot syndrome: a randomized, double-blinded, placebo-controlled clinical trial. Phytother Res. 2017;31:1323-1329.", "ArticleIdList": ["28635153"]}, {"Citation": "Miller KK, Gorcey L, McLellan BN. Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management. J Am Acad Dermatol. 2014;71:787-794.", "ArticleIdList": ["24795111"]}, {"Citation": "Wei XC, Zhu LQ, Wang H, et al. Efficacy of traditional Chinese medicines in preventing oxaliplatin-induced peripheral neurotoxicity in cancer patients: a network meta-analysis. Chin Herb Med. 2017;9:161-168."}, {"Citation": "Hoshino N, Ganeko R, Hida K, Sakai Y. Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Int J Clin Oncol. 2018;23:434-442.", "ArticleIdList": ["29270698"]}, {"Citation": "Cascella M, Muzio MR. Potential application of the Kampo medicine goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy. J Integr Med. 2017;15:77-87.", "ArticleIdList": ["28285612"]}, {"Citation": "Kuriyama A, Endo K. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Supportive Care Cancer. 2018;26:1051-1059.", "ArticleIdList": ["29280005"]}, {"Citation": "Derksen TME, Bours MJL, Mols F, Weijenberg MP. Lifestyle-related factors in the self-management of hemotherapy-induced peripheral neuropathy in colorectal cancer: a systematic review. Evid Based Complement Alternat Med. 2017;2017:7916031. doi:10.1155/2017/7916031", "ArticleIdList": ["10.1155/2017/7916031", "PMC5376448", "28400846"]}, {"Citation": "Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; 2011."}, {"Citation": "Bao YJ, Qiu YY, Hu SJ, et al. The effect of Jianpibushen formula on postoperative adjuvant treatment of colorectal cancer [\u5065\u813e\u8865\u80be\u65b9\u5bf9\u5927\u80a0\u764c\u672f\u540e\u8f85\u52a9\u6cbb\u7597\u7684\u7597\u6548]. Shanghai Med J. 2014;37:984-986."}, {"Citation": "Cai ZB. Clinical Observation of Prevention of Oxaliplatin-Induced Neurotoxicity by Wenjinghuoxue Formula Bath [\u6e29\u7ecf\u6d3b\u8840\u65b9\u5916\u6d17\u9884\u9632\u5965\u6c99\u5229\u94c2\u5468\u56f4\u795e\u7ecf\u6bd2\u6027\u7684\u4e34\u5e8a\u89c2\u5bdf]. Guangzhou, China: Guangzhou University of Chinese Medicine; 2016;12-16."}, {"Citation": "Cao B. The clinical efficacy of Yiqijianpi decoction combined with FOLFOX4 in postoperative colorectal cancer patients [\u76ca\u6c14\u5065\u813e\u6c64\u8054\u5408FOLFOX4\u65b9\u6848\u6cbb\u7597\u7ed3\u76f4\u80a0\u764c\u672f\u540e\u60a3\u8005\u7684\u4e34\u5e8a\u7597\u6548]. Cancer Res Prev Treat. 2011;38:820-822."}, {"Citation": "Chen CG. Clinical Trial of Jianpiyishen and Huayujiedu Therapy Combined With FOLFOX4 for Medium and Advanced Colorectal Cancer [\u5065\u813e\u76ca\u80be,\u5316\u7600\u89e3\u6bd2\u6cd5\u8054\u5408FOLFOX-4\u65b9\u6848\u6cbb\u7597\u4e2d,\u665a\u671f\u5927\u80a0\u764c\u7684\u4e34\u5e8a\u7814\u7a76]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2005;20-31."}, {"Citation": "Chen XJ. Clinical Trial of Jianpihuashiquyu Formula Combined With Chemotherapy for Advanced Colorectal Cancer [\u5065\u813e\u5316\u6e7f\u795b\u7600\u65b9\u8054\u5408\u5316\u7597\u6cbb\u7597\u665a\u671f\u5927\u80a0\u764c\u7684\u4e34\u5e8a\u7814\u7a76]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2010:14-20."}, {"Citation": "Chen Y. Experimental Study of the Influence of Weitiaosanhao Formula on Inflammatory Microenvironment of Colorectal Cancer and Clinical Trial of the Formula Plus SOX in Colorectal Cancer Patients [\u5fae\u8c03\u4e09\u53f7\u65b9\u5bf9\u5927\u80a0\u764c\u708e\u6027\u5fae\u73af\u5883\u5f71\u54cd\u7684\u5b9e\u9a8c\u7814\u7a76\u53ca\u5176\u8054\u5408SOX\u65b9\u6848\u7684\u4e34\u5e8a\u7814\u7a76]. Nanjing: Nanjing University of Traditional Chinese Medicine; 2014:28-40."}, {"Citation": "Cheng XL, Huo JG, Wang DW, et al. Herbal medicine AC591 prevents oxaliplatin-induced peripheral neuropathy in animal model and cancer patients. Front Pharmacol. 2017;8:344.", "ArticleIdList": ["PMC5461429", "28638341"]}, {"Citation": "Fang ZH, Li Y, Chen Y, Chen DL. Clinical observation of Jianpikangai formula combined with chemotherapy for advanced colorectal cancer [\u5065\u813e\u6297\u764c\u65b9\u914d\u5408\u5316\u7597\u6cbb\u7597\u665a\u671f\u5927\u80a0\u764c31\u4f8b]. Shanghai J Tradit Chin Med. 2009;43:29-31."}, {"Citation": "Feng YQ. Clinical observation of prevention and treatment of oxaliplatin-induced neurotoxicity by Chinese medicine hand and foot bath [\u4e2d\u836f\u5916\u6d17\u9632\u6cbb\u5965\u6c99\u5229\u94c2\u795e\u7ecf\u6bd2\u6027\u7684\u62a4\u7406\u89c2\u5bdf]. Straits Pharm J. 2011;23:203-204."}, {"Citation": "Gai L, Shi B, Zhang XB. The effect of Shenyi capsule plus XELOX versus XELOX for colorectal cancer [\u53c2\u4e00\u80f6\u56ca\u8054\u5408XELOX\u65b9\u6848\u4e0e\u5355\u7eafXELOX\u65b9\u6848\u6cbb\u7597\u665a\u671f\u76f4\u80a0\u764c\u7684\u4e34\u5e8a\u89c2\u5bdf]. Mod J Integ Trad Chin West Med. 2010;19:1066-1067."}, {"Citation": "Gao J, Yan SH, Li DP, et al. Clinical observation of Chinese medicine bath for prevention of oxaliplatin-induced neurotoxicity [\u4e2d\u836f\u6ce1\u6d17\u9884\u9632\u5965\u6c99\u5229\u94c2\u6240\u81f4\u795e\u7ecf\u6bd2\u6027\u7684\u7597\u6548\u89c2\u5bdf]. Hebei J Trad Chin Med. 2015;37:994-996."}, {"Citation": "Gao XM. Clinical Trial of Modified Bazhen Decoction on Decreasing the Adjuvant Chemotherapy Side Effects in Postoperative Colon Cancer Patients With Deficiency of Qi and Blood [\u516b\u73cd\u6c64\u52a0\u51cf\u5bf9\u7ed3\u80a0\u764c\u672f\u540e\u6c14\u8840\u4e24\u865a\u578b\u60a3\u8005\u8f85\u52a9\u5316\u7597\u51cf\u6bd2\u4f5c\u7528\u7684\u4e34\u5e8a\u7814\u7a76]. Fuzhou, China: Fujian University of Traditional Chinese Medicine; 2015:3-11."}, {"Citation": "He JP, Qu JH. Clinical trial of Gubenjiedu therapy plus FOLFOX4 for advanced or recurrent rectal cancer [\u56fa\u672c\u89e3\u6bd2\u6cd5\u8054\u5408FOLFOX4\u65b9\u6848\u5316\u7597\u6cbb\u7597\u665a\u671f\u6216\u590d\u53d1\u6027\u76f4\u80a0\u764c\u7684\u4e34\u5e8a]. J Sichuan Trad Chin Med. 2013;31:76-78."}, {"Citation": "He ZF. Clinical Trial of Yiqijianpi and Huayujiedu Formula Combined With FOLFOX for Postoperative Colorectal Cancer [\u76ca\u6c14\u5065\u813e,\u5316\u7600\u89e3\u6bd2\u65b9\u5408FOLFOX\u65b9\u6848\u5316\u7597\u6cbb\u7597\u672f\u540e\u5927\u80a0\u764c\u7684\u4e34\u5e8a\u7814\u7a76]]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2006:8-17."}, {"Citation": "Hou ZB. The Effect of Modified Banxiaxiexin Decoction for Postoperative Colorectal Cancer and Related Tumor Markers [\u534a\u590f\u6cfb\u5fc3\u6c64\u52a0\u51cf\u5bf9\u7ed3\u76f4\u80a0\u764c\u672f\u540e\u7684\u4e34\u5e8a\u7597\u6548\u53ca\u76f8\u5173\u8840\u6e05\u80bf\u7624\u6807\u5fd7\u7269\u7684\u5f71\u54cd]. Guiyang, China: Guiyang College of Traditional Chinese Medicine; 2014:7-21."}, {"Citation": "Hu B, Li G, An HM, et al. Clinical trial of Tenglong Buzhong decoction plus chemotherapy for advanced colorectal cancer [\u85e4\u9f99\u8865\u4e2d\u6c64\u8054\u5408\u5316\u7597\u6cbb\u7597\u665a\u671f\u5927\u80a0\u764c\u4e34\u5e8a\u7814\u7a76]. Chin Arch Trad Chin Med. 2015;33:37-39."}, {"Citation": "Hu FS, Zhang Q, Wang XM, et al. Clinical trial of Gubenxiaoliu capsule plus FOLFOX4 for advanced colorectal cancer [\u56fa\u672c\u6d88\u7624\u80f6\u56ca\u8054\u5408FOLFOX4\u65b9\u6848\u6cbb\u7597\u665a\u671f\u5927\u80a0\u764c\u7684\u4e34\u5e8a\u7814\u7a76]. Chin J Inf Trad Chin Med. 2007;14:13-14."}, {"Citation": "\nHu QQ.\nClinical trial of Chinese medicine three-step\ncytotherapy plus modified XELOX for stage IV colorectal\ncancer [\u4e2d\u836f\u4e09\u6b65\u5468\u671f\u7597\u6cd5\u8054\u5408\u6539\u826fXELOX\u65b9\u6848\u6cbb\u7597\u2163\u671f\u5927\u80a0\u764c\u7684\u4e34\u5e8a\u7814\u7a76]. http://cdmd.cnki.com.cn/Article/CDMD-10315-1014127885.htm.\nPublished 2013. Accessed Novenmber 21, 2018."}, {"Citation": "Huang L, Guo JH. Clinical trial of Yiqihuatansanjie formula plus XELOX for advanced recurrent colon cancer [\u76ca\u6c14\u5316\u75f0\u6563\u7ed3\u65b9\u8054\u5408XELOX\u5316\u7597\u65b9\u6848\u6cbb\u7597\u665a\u671f\u590d\u53d1\u6027\u7ed3\u80a0\u764c\u7684\u4e34\u5e8a\u7814\u7a76]. Chin Arch Trad Chin Med. 2014;32:670-672."}, {"Citation": "Jiang ZM, Hu LQ, Jiang SS. Clinical observation of modified Sijunzi decoction plus FOLFOX6 for advanced colorectal cancer [\u52a0\u5473\u56db\u541b\u5b50\u6c64\u8054\u5408FOLFOX6\u65b9\u6848\u6cbb\u7597\u665a\u671f\u7ed3\u76f4\u80a0\u764c\u4e34\u5e8a\u89c2\u5bdf]. Zhejiang Clin Med J. 2014;16:1296-1298."}, {"Citation": "Jiao SJ, Fan CQ, An GY, et al. Clinical trial of Zibu decoction plus capecitabine as maintenance treatment in advanced colorectal cancer with deficiency of Qi and Blood after first-line chemotherapy [\u6ecb\u8865\u6c64\u8054\u5408\u5361\u57f9\u4ed6\u6ee8\u7ef4\u6301\u6cbb\u7597\u4e00\u7ebf\u5316\u7597\u540e\u6c14\u8840\u4e24\u865a\u8bc1\u665a\u671f\u7ed3\u76f4\u80a0\u764c\u7684\u7814\u7a76]. Mod J Int Trad Chin West Med. 2016;25:1258-1260,1317."}, {"Citation": "Ke SW, Huang GD, Zhao J. Clinical trial of Kangaiyiliu formula plus CapeOx for advanced colorectal cancer [\u6297\u764c\u6291\u7624\u65b9\u8054\u5408CapeOx\u65b9\u6848\u6cbb\u7597\u665a\u671f\u7ed3\u76f4\u80a0\u764c]. Chin Trad Patent Med. 2015;37:49-54."}, {"Citation": "Kono T, Hata T, Morita S, et al. Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double\u2011blind, placebo\u2011controlled trial of goshajinkigan to prevent oxaliplatin\u2011induced neuropathy. Cancer Chemother Pharmacol. 2013;72:1283-1290.", "ArticleIdList": ["PMC3834178", "24121454"]}, {"Citation": "Lai YQ, Chen NJ, Wu DH, Chen YY. Clinical observation of prevention of oxaliplatin-induced neurotoxicity by Jianpiyishen therapy in 27 cases [\u5065\u813e\u76ca\u80be\u6cd5\u9884\u9632\u5965\u6c99\u5229\u94c2\u5468\u56f4\u795e\u7ecf\u6bd2\u602727\u4f8b. \u798f\u5efa\u4e2d\u533b\u836f]. Fujian J Trad Chin Med. 2009;40:22-23."}, {"Citation": "Li J. Clinical Observation and Mechanism Research of Fuzhenghuayujiedusanjie Method Plus Chemotherapy for Advanced Colorectal Cancer [\u6276\u6b63\u5316\u7600\u89e3\u6bd2\u6563\u7ed3\u914d\u5408\u5316\u7597\u6cbb\u7597\u665a\u671f\u5927\u80a0\u764c\u7684\u4e34\u5e8a\u89c2\u5bdf\u53ca\u673a\u7406\u7814\u7a76]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2011:12-24."}, {"Citation": "Li L. Clinical trial of Jianpihuashiquyu Formula Plus Caplri for Advanced Colorectal Cancer [\u5065\u813e\u5316\u6e7f\u795b\u7600\u65b9\u8054\u5408Caplri\u65b9\u6848\u5316\u7597\u6cbb\u7597\u665a\u671f\u5927\u80a0\u764c\u7684\u4e34\u5e8a\u7814\u7a76]. Nanjing, China:Nanjing University of Traditional Chinese Medicine; 2007:11-20."}, {"Citation": "\nLi LC.\nClinical and experimental study of compound\nChangtai in treating colorectal cancer[\u590d\u65b9\u80a0\u6cf0\u6cbb\u7597\u5927\u80a0\u764c\u7684\u4e34\u5e8a\u548c\u5b9e\u9a8c\u7814\u7a76]. http://cdmd.cnki.com.cn/Article/CDMD-10315-2009251849.htm.\nAccessed November 21, 2018."}, {"Citation": "Li N. Clinical Trial of Jianpiyishen Therapy for Postoperative Colorectal Cancer [\u5065\u813e\u76ca\u80be\u6cd5\u6cbb\u7597\u672f\u540e\u5927\u80a0\u764c\u7684\u4e34\u5e8a\u7814\u7a76]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2012;10-18."}, {"Citation": "Li YJ, Chen JZ, Huang WX, Li XF. Clinical observation of Wenshenjianpi formula plus chemotherapy for elderly patients with advanced colorectal cancer [\u6e29\u80be\u5065\u813e\u65b9\u8054\u5408\u5316\u7597\u6cbb\u7597\u8001\u5e74\u8fdb\u5c55\u671f\u5927\u80a0\u764c\u7684\u4e34\u5e8a\u89c2\u5bdf]. Fujian J Trad Chin Med. 2007;38:13-14."}, {"Citation": "Liang XS, Chen MC, Chen DL, Lin Q. Clinical observation of prevention and treatment of oxaliplatin-induced neurotoxicity by Yiqilixueyufeng decoction in 46 cases [\u76ca\u6c14\u7406\u8840\u6108\u98ce\u6c64\u9632\u6cbb\u5965\u6c99\u5229\u94c2\u6240\u81f4\u5916\u5468\u795e\u7ecf\u6bd2\u6027\u53cd\u5e9446\u4f8b]. Chin J Trad Med Sci Technol. 2012;19:94."}, {"Citation": "Liang XS, Yan LL, Lin Q. Clinical observation of prevention and treatment of oxaliplatin-induced neurotoxicity by Lixuequfeng decoction [\u7406\u8840\u795b\u98ce\u6c64\u9632\u6cbb\u5927\u80a0\u764c\u672f\u540e\u5965\u6c99\u5229\u94c2\u6240\u81f4\u5916\u5468\u795e\u7ecf\u6bd2\u6027\u53cd\u5e9474\u4f8b]. Zhejiang J Tradl Chin Med. 2015;50:522-523."}, {"Citation": "Liu JP, Jiang J, Wei H, et al. Clinical observation of Huachansu capsule plus XELOX for advanced colon cancer [\u534e\u87fe\u7d20\u8054\u5408XELOX\u65b9\u6848\u6cbb\u7597\u665a\u671f\u7ed3\u80a0\u764c\u7684\u4e34\u5e8a\u7597\u6548\u89c2\u5bdf]. Med J West China. 2017;29:1560-1563."}, {"Citation": "Liu P, Liu JH, Zhu DQ, et al. Clinical observation of Boerning capsule plus FOLFOX4 for colon cancer [\u535a\u5c14\u5b81\u80f6\u56ca\u8054\u5408FOLFOX4\u65b9\u6848\u6cbb\u7597\u7ed3\u80a0\u764c\u7684\u4e34\u5e8a\u89c2\u5bdf]. Chin J Clin Oncol. 2007;34:89-91."}, {"Citation": "Liu SC. Clinical Observation of Yiqiyangying Method Plus FOLFOX6 for Medium and Advanced Colorectal Cancer [\u76ca\u6c14\u517b\u9634\u4e2d\u836f\u914d\u5408FOLFOX6\u65b9\u6848\u5316\u7597\u6cbb\u7597\u4e2d\u665a\u671f\u5927\u80a0\u764c\u7684\u4e34\u5e8a\u89c2\u5bdf]. Beijing, China: Beijing University of Chinese Medicine; 2011:26-35."}, {"Citation": "Liu YF, Zhu GY, Han L, Liu J, Ma T, Yu H. Clinical study on the prevention of oxaliplatin-induced neurotoxicity with Guilongtongluofang: results of a randomized, double-blind, placebo-controlled trial. Evid Based Complement Alternat Med. 2013;2013:541217.", "ArticleIdList": ["PMC3845400", "24324514"]}, {"Citation": "Ma J, Lu CW, Cai DF, Xu JM. Clinical observation of Jianpixiaoliu formula plus FOLFOX4 for advanced colon cancer [\u5065\u813e\u6d88\u7624\u65b9\u8054\u5408FOLFOX4\u65b9\u6848\u6cbb\u7597\u665a\u671f\u7ed3\u76f4\u80a0\u764c\u4e34\u5e8a\u89c2\u5bdf]. J New Chin Med. 2015;47:208-210."}, {"Citation": "Mao WD, Jiang LX, Zhou JY, Jiang HM. The effect of Chinese medicine plus chemotherapy to prevent the recurrence and metastasis of postoperative colorectal cancer [\u4e2d\u836f\u52a0\u5316\u7597\u5bf9\u5927\u80a0\u764c\u672f\u540e\u590d\u53d1\u8f6c\u79fb\u7684\u5f71\u54cd\u7814\u7a76]. Med J China. 2011;8:70-72."}, {"Citation": "Mao ZJ, Zhu LM, Lu YL, Shen KP. The effect of Jianpi therapy plus FOLFOX on cancer-related fatigue, Th1/Th2 immune response balance and peripheral neuropathy in postoperative colon cancer patients [\u4e2d\u533b\u5065\u813e\u6cd5\u914d\u5408FOLFOX\u5316\u7597\u65b9\u6848\u5bf9\u7ed3\u80a0\u764c\u672f\u540e\u60a3\u8005\u764c\u56e0\u6027\u75b2\u4e4f, Th1/Th2\u514d\u75ab\u5e94\u7b54\u5e73\u8861\u53ca\u5468\u56f4\u795e\u7ecf\u75c5\u53d8\u7684\u5f71\u54cd]. Mod J Int Trad Chin West Med. 2017;26:4027-4030."}, {"Citation": "Nishioka M, Shimada M, Kurita N, et al. The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen. Int J Clin Oncol. 2011;16:322-327.", "ArticleIdList": ["21258836"]}, {"Citation": "Oki E, Emi Y, Kojima H, et al. Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo\u2011controlled, double\u2011blind, randomized phase III study. Int J Clin Oncol. 2015;20:767-775.", "ArticleIdList": ["25627820"]}, {"Citation": "Pan RR. Clinical Trial of Erlingyiren Decoction Plus XELOX in Postoperative Colorectal Cancer Patients With Spleen Deficiency, Dampness and Heat Syndrome [\u4e8c\u82d3\u82e1\u4ec1\u6c64\u8054\u5408XELOX\u65b9\u6848\u5316\u7597\u6cbb\u7597\u80a0\u764c\u672f\u540e\u813e\u865a\u6e7f\u70ed\u8bc1\u7684\u4e34\u5e8a\u7814\u7a76]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2017:11-21."}, {"Citation": "Pu QH. Experimental Study of the Effect of Weitiaosanhao Formula on VEGF, nm23-H1 and CK20 for Colorectal Cancer With Liver Metastasis and Clinical Trial of the Formula Plus FOLFOX4 in Colorectal Cancer With Liver Metastasis Patients [\u5fae\u8c03\u4e09\u53f7\u65b9\u5bf9\u5927\u80a0\u764c\u809d\u8f6c\u79fbVEGF, nm23-H1\u548cCK20\u7684\u5f71\u54cd\u7684\u5b9e\u9a8c\u7814\u7814\u7a76\u53ca\u5176\u8054\u5408FOLFOX4\u65b9\u6848\u7684\u4e34\u5e8a\u7814\u7a76]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2012;31-41."}, {"Citation": "Qin CY. Clinical Observation of Prevention and Treatment of Chemotherapy Side Effects by Jianpiyishen Therapy in Medium and Advanced Colorectal Cancer [\u5065\u813e\u76ca\u80be\u6cbb\u6cd5\u9632\u6cbb\u4e2d\u665a\u671f\u7ed3\u76f4\u80a0\u764c\u5316\u7597\u6bd2\u526f\u53cd\u5e94\u7684\u4e34\u5e8a\u89c2\u5bdf]. Beijing, China: Beijing University of Chinese Medicine; 2014;25-35."}, {"Citation": "Shi RQ. Clinical Trial of Yiqijianpi Formula Plus XELOX for Postoperative Colorectal Cancer [\u76ca\u6c14\u5065\u813e\u65b9\u8054\u5408XELOX\u65b9\u6848\u6cbb\u7597\u5927\u80a0\u764c\u672f\u540e\u60a3\u8005\u7684\u4e34\u5e8a\u7814\u7a76]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2017;8-15."}, {"Citation": "Shu JH, Zhou RY, Zhong Y, Wu LY. Clinical observation of Yiqijiedu decoction plus CapeOX for advanced colorectal cancer [\u76ca\u6c14\u89e3\u6bd2\u6c64\u8054\u5408CapeOX\u65b9\u6848\u6cbb\u7597\u665a\u671f\u5927\u80a0\u764c45\u4f8b]. Shanghai J Trad Chin Med. 2011;45:33-35,45."}, {"Citation": "Wang H. Clinical observation of Yiqihuoxuebuchang decoction plus chemotherapy for postoperative rectal cancer [\u76ca\u6c14\u6d3b\u8840\u8865\u80a0\u6c64\u5408\u5316\u7597\u6cbb\u7597\u76f4\u80a0\u764c\u672f\u540e\u60a3\u8005\u7684\u7597\u6548\u89c2\u5bdf]. J Liaoning Univ Trad Chin Med. 2008;10:81-82."}, {"Citation": "Wang JM. Clinical Observation of Jianpiyangyingqushijiedu Therapy Plus XELOX for Medium and Advanced Colorectal Cancer [\u5065\u813e\u517b\u9634\u795b\u6e7f\u89e3\u6bd2\u6cd5\u8054\u5408XELOX\u65b9\u6848\u6cbb\u7597\u4e2d\u665a\u671f\u7ed3\u76f4\u80a0\u764c\u7684\u4e34\u5e8a\u7597\u6548\u89c2\u5bdf]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2016;11-18."}, {"Citation": "Wang JZ, Ke YH, Liu PC, et al. Clinical trial of Yichangning formula plus FOLFOX4 for advanced colorectal cancer in 30 cases [\u5b9c\u80a0\u5b81\u65b9\u8054\u5408FOLFOX-4\u65b9\u6848\u6cbb\u7597\u665a\u671f\u7ed3\u76f4\u80a0\u764c30\u4f8b\u4e34\u5e8a\u7814\u7a76]. Fujian J Trad Chin Med. 2011;42:23-24."}, {"Citation": "Wang Q. Clinical observation of prevention and treatment of oxaliplatin-induced neurotoxicity by Huangqiguizhiwuwu decoction hand and foot bath plus calcium gluconate and magnesium sulphate [\u9ec4\u82aa\u6842\u679d\u4e94\u7269\u6c64\u624b\u8db3\u6d74\u8054\u5408\u9499\u9541\u5408\u5242\u9632\u6cbb\u5965\u6c99\u5229\u94c2\u795e\u7ecf\u6bd2\u6027\u7684\u4e34\u5e8a\u89c2\u5bdf]. Mod J Integ Trad Chin West Med. 2015;24:318-320."}, {"Citation": "Wang QY, He W, Lin Q, Li LR. Clinical observation of Chinese medicine plus chemotherapy for advanced colon cancer [\u4e2d\u836f\u8054\u5408\u5316\u7597\u6cbb\u7597\u665a\u671f\u7ed3\u80a0\u764c\u7684\u4e34\u5e8a\u7597\u6548\u89c2\u5bdf]. Mod Digestion Intervent. 2015;20:387-389."}, {"Citation": "Wang SW. Clinical Observation of Tongtai Decoction Plus XELOX for Advanced Colorectal Cancer [\u901a\u6cf0\u5408\u5242\u8054\u5408XELOX\u65b9\u6848\u5316\u7597\u6cbb\u7597\u665a\u671f\u5927\u80a0\u764c\u7597\u6548\u4e34\u5e8a\u89c2\u5bdf]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2012;14-23."}, {"Citation": "Xie W. Clinical Observation on the Inhibitory Effect of Xiaoliu Decoction for Antiangiogenic VEGF in Colorectal Cancer [\u6d88\u7624\u6c64\u5bf9\u7ed3\u76f4\u80a0\u764cVEGF\u6291\u5236\u4f5c\u7528\u7684\u4e34\u5e8a\u7814\u7a76]. Nanning, China: Guangxi University of Traditional Chinese Medicine; 2010;6-14."}, {"Citation": "Xu C, Yu XW, Li M. Clinical observation of modified Xiangshaliujunzi decoction plus FOLFIRI for advanced colon cancer [\u52a0\u5473\u9999\u7802\u516d\u541b\u5b50\u6c64\u8054\u5408FOLFIRI\u65b9\u6848\u6cbb\u7597\u665a\u671f\u7ed3\u80a0\u764c]. Chin J Clin Med. 2012;19:36-37."}, {"Citation": "Xu XQ, Qi YF. Clinical observation of Yiqihexue therapy for chemotherapy-induced neurotoxicity in colorectal cancer patients [\u76ca\u6c14\u548c\u8840\u6cd5\u6cbb\u7597\u5927\u80a0\u764c\u60a3\u8005\u5316\u7597\u6240\u81f4\u795e\u7ecf\u6bd2\u6027\u7597\u6548\u5206\u6790]. World J Integ Trad West Med. 2014;9:1087-1089."}, {"Citation": "Yang CD. Clinical observation on the effect of Chinese herbal fumigation on the peripheral neurotoxicity of oxaliplatin [\u4e2d\u836f\u718f\u6d17\u6cbb\u7597\u5965\u6c99\u5229\u94c2\u6240\u81f4\u5468\u56f4\u795e\u7ecf\u6bd2\u6027\u7684\u4e34\u5e8a\u89c2\u5bdf]. China Clin Nurs. 2015;7:234-235."}, {"Citation": "Ye HQ, Zhong MW, Chen XL, Tang RD. Clinical observation of Qifulongkui decoction plus chemotherapy for metastatic colorectal cancer in 30 cases [\u82aa\u9644\u9f99\u8475\u6c64\u8054\u5408\u5316\u7597\u6cbb\u7597\u8f6c\u79fb\u6027\u7ed3\u76f4\u80a0\u764c30\u4f8b\u4e34\u5e8a\u89c2\u5bdf]. J Trad Chin Med. 2016;57:1490-1492,1496."}, {"Citation": "Zeng JQ, Li ZP, Wang X. Clinical observation of Chinese medicine plus chemotherapy for advanced colorectal cancer in 30 cases [\u4e2d\u533b\u8fa8\u8bc1\u65bd\u6cbb\u914d\u5408\u5316\u7597\u6cbb\u7597\u665a\u671f\u5927\u80a0\u764c30\u4f8b]. J Jiangxi Univ Trad Chin Med. 2008;20:39-41."}, {"Citation": "Zeng JY, He J, Wang QJ, et al. The effect of Xiaoliu decoction plus hyperthermic intraperitoneal chemotherapy on postoperative immune function and VEGF for advanced colorectal cancer [\u6d88\u7624\u6c64\u8054\u5408\u70ed\u704c\u6ce8\u5316\u7597\u5bf9\u8fdb\u5c55\u671f\u7ed3\u76f4\u80a0\u764c\u672f\u540e\u514d\u75ab\u529f\u80fd\u548c\u8840\u6e05\u8840\u7ba1\u5185\u76ae\u751f\u957f\u56e0\u5b50\u6c34\u5e73\u7684\u5f71\u54cd]. J Guangxi Med Univ. 2010;27:415-416."}, {"Citation": "Zhang C, Han ZG. Clinical observation of Chinese medicine plus chemotherapy for postoperative colorectal cancer [\u5316\u7597\u8054\u5408\u4e2d\u836f\u6cbb\u7597\u5728\u7ed3\u76f4\u80a0\u764c\u672f\u540e\u7684\u4e34\u5e8a\u6548\u679c\u89c2\u5bdf]. China Mod Med. 2015;22:135-138,141."}, {"Citation": "Zhang Q, Wang XM, Yang GW, et al. Clinical trial of Gubenxiaoliu capsule plus FOLFOX4 for advanced colorectal cancer [\u56fa\u672c\u6d88\u7624\u80f6\u56ca\u8054\u5408FOLFOX4\u5316\u7597\u65b9\u6848\u6cbb\u7597\u665a\u671f\u5927\u80a0\u764c\u7684\u4e34\u5e8a\u7814\u7a76]. Beijing J Trad Chin Med. 2010;29:255-257."}, {"Citation": "Zhang WW, Chen J, Xie GQ, et al. Clinical trial of Jianpijiedu formula plus capecitabine for advanced colorectal cancer [\u5065\u813e\u89e3\u6bd2\u65b9\u7ed3\u5408\u5361\u57f9\u4ed6\u6ee8\u7247\u6cbb\u7597\u665a\u671f\u5927\u80a0\u764c\u4e34\u5e8a\u7814\u7a76]. J Shanghai Univ Trad Chin Med. 2013;27:31-34."}, {"Citation": "Zhong MW, Ye HQ, Li QZ, et al. The effect of Qifulongkui decoction plus chemotherapy on quality of life in the patient with metastatic colorectal cancer [\u82aa\u9644\u9f99\u8475\u6c64\u8054\u5408\u5316\u7597\u5bf9\u8f6c\u79fb\u6027\u7ed3\u76f4\u80a0\u764c\u60a3\u8005\u751f\u5b58\u8d28\u91cf\u7684\u5f71\u54cd]. Mod J Integ Trad Chin West Med. 2016;25:1980-1982."}, {"Citation": "Zhu FY, Wang B, Ai Y, et al. Clinical trial of Jianpiyiqijiedu formula plus chemotherapy for advanced colorectal cancer [\u5065\u813e\u76ca\u6c14\u89e3\u6bd2\u65b9\u8054\u5408\u5316\u7597\u6cbb\u7597\u665a\u671f\u5927\u80a0\u764c\u4e34\u5e8a\u7814\u7a76]. Mod J Integ Trad Chin West Med. 2016;25:261-263."}, {"Citation": "Levi F, Misset JL, Brienza S, et al. A chronopharmacologic phase-II clinical-trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal-cancer. Cancer. 1992;69:893-900.", "ArticleIdList": ["1735081"]}, {"Citation": "Chen M, May BH, Zhou IW, Xue CC, Zhang Al. FOLFOX 4 combined with herbal medicine for advanced colorectal cancer: a systematic review. Phytother Res. 2014;28:976-991.", "ArticleIdList": ["24343974"]}, {"Citation": "Hosokawa A, Ogawa K, Ando T, et al. Preventive effect of traditional Japanese medicine on neurotoxicity of FOLFOX for metastatic colorectal cancer: a multicenter retrospective study. Anticancer Res. 2012;32:2545-2550.", "ArticleIdList": ["22753712"]}, {"Citation": "Kono T, Mamiya N, Chisato N, et al. Efficacy of Goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer. Evid Based Complement Alternat Med. 2011;2011:418481.", "ArticleIdList": ["PMC3135601", "19952054"]}, {"Citation": "Yoshida N, Hosokawa T, Ishikawa T, et al. Efficacy of goshajinkigan for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients. J Oncol. 2013;2013:139740.", "ArticleIdList": ["PMC3838827", "24307899"]}, {"Citation": "Kaku H, Kumagai S, Onoue H, et al. Objective evaluation of the alleviating effects of Goshajinkigan on peripheral neuropathy induced by paclitaxel/carboplatin therapy: a multicenter collaborative study. Exp Ther Med. 2012;3:60-65.", "ArticleIdList": ["PMC3438785", "22969845"]}, {"Citation": "Chen M, May BH, Zhou IW, et al. Meta-analysis of oxaliplatin-based chemotherapy combined with traditional medicines for colorectal cancer: contributions of specific plants to tumor response. Integr Cancer Ther. 2016;15:40-59.", "ArticleIdList": ["PMC5736077", "26254190"]}, {"Citation": "Chen M, May BH, Zhou IW, Sze DM, Xue CC, Zhang AL. Oxaliplatin-based chemotherapy combined with traditional medicines for neutropenia in colorectal cancer: a meta-analysis of the contributions of specific plants. Crit Rev Oncol Hematol. 2016;105:18-34.", "ArticleIdList": ["27497028"]}]}], "History": [{"Year": "2018", "Month": "12", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "12", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "12", "Day": "10"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30526124", "PMC7240882", "10.1177/1534735418817833"]}}]}